The IPO market for biopharma companies is heating up.At least three companies with venture capital backing have filed plans to go public this month. All of them enjoy the backing of hedge funds, which ...

After building the Illinois Police Officers' Pension Investment Fund from scratch since joining in May 2021 as the plan’s debut investment chief, Kent Custer is ready to make sizeable investments in ...

A number of Tiger Cubs and other tech-focused hedge funds are enjoying strong years. But none of them comes close to the gargantuan gains generated by Flight Deck Capital.The tech-focused hedge fund ...

Third Point posted a strong 7.9 percent gain in the second quarter despite recording flat results in June. As a result, the multistrategy hedge fund headed by Dan Loeb is up 7.4 percent for the year, ...

Several prominent biotech-focused hedge funds are backing Talawar Therapeutics' merger with JATT II Acquisition, a special purpose acquisition company that found a merger partner just over two months ...

So much for the venture capital revival.Most hedge funds that invest in private markets were less active in the second quarter than in the previous period, according to an analysis of Crunchbase data.

The Doris Duke Foundation’s long biotechnology bet is paying off after a five-year winter. The $2.2 billion portfolio has steadily expanded its exposure to health and life sciences as part of a ...

Bill Ackman’s hedge fund is having a good year, but it has sold out of two big losers: Chipotle and Nike. Pershing Square Holdings, Ackman’s publicly traded fund, was up more than 17 percent as of ...

With AI-related stocks accounting for 75 percent of S&P 500 returns since ChatGPT was launched in 2023 — along with 80 percent of earnings growth and 90 percent of capital spending — there’s little ...

Daniel Michalow was a golden child at D.E. Shaw, the now-$70 billion hedge fund he joined in 2004 at the age of 21, straight out of Harvard. By the end of 2011, he had become the firm’s youngest ...

After a year marked by trade wars, historic market volatility, and questions about what once seemed immutable — the U.S. dollar as the world’s reserve currency and the independence of the Federal ...

Private equity is facing lackluster fundraising and few options to sell portfolio companies — but that has been a tailwind for the secondary market, which investors use to sell their stakes in PE ...